Interventional therapy is one of the measures to restore blood flow in basilar artery infarction, and intravenous thrombolysis is also a treatment to restore blood flow. Treatment of basilar artery infarction includes general treatment such as oxygenation and cardiac monitoring, as well as specific treatment such as thrombolysis and intervention. Whether interventional therapy is optimal should be judged according to the patient’s specific situation.
1. Intravenous thrombolysis: recombinant tissue-type plasminogen activator (rtPA) or urokinase can be used. rtPA should be applied preferably within 3 hours of the onset of the disease, and should not be used in patients with contraindications such as a history of intracranial hemorrhage, a history of stroke in the last 3 months, suspected subarachnoid hemorrhage, and active internal bleeding. Urokinase can be applied within 6 hours of onset, with contraindications similar to rtPA.
2. Interventional therapy: including arterial thrombolysis, bridging, mechanical thrombolysis, stenting and so on. After evaluation of the patient, if the recanalization rate of intravenous thrombolysis is low or the efficacy is not good, interventional therapy can be used for the screened patients. The evaluation process should be performed by a specialized physician.
It is recommended that the best treatment be selected under the guidance of a physician, depending on factors such as the patient’s condition and the time of onset of the disease, and that medications be taken under the direction of a physician.